SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000912057-00-029925
Filing Date
2000-06-27
Accepted
2000-06-27 00:00:00
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II,L.P.BIOTECHNOLOGY VALUE FUND L PBVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A sc13da.txt SC 13D/A 17483
  Complete submission text file 0000912057-00-029925.txt   19857
Mailing Address
Business Address 1375 AKRON STREET P O BOX 1001 COPIAGUE NY 11726 5167892600
AMERICAN BIOGENETIC SCIENCES INC (Subject) CIK: 0000856984 (see all company filings)

IRS No.: 112655906 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45379 | Film No.: 661817
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice